providing mental health &
substance abuse  services for
the people of Alameda County ...  

 
Click here to go to homepage!
 

Medicare Part D
Med. & Pharmacy User Guide
Guidelines for Practices
Medication Consent
MIA Medication Program
Antipsychotic Monitoring
Drug Information Updates
Continuing Med. Education
Newsletter

Print This Page


Click here to send us your feedback.

Last Updated:  12/05/2005

Copyright © 2005
Alameda County Behavioral Health Care Services

 


Olanzapine (Zyprexa): Clinical and Economic Outcomes  Printer Friendly Version


Inside This Section
[ Service Utilization Changes ][ Cost Changes ][ Cost Changes Over 2 Years ]

 
A total of 56 patients were included in this two-year study. Fifty-six patients continued to receive olanzapine for 12 consecutive months. The types of service utilization, medication costs, and overall costs were measured in a 1-year period prior to and then after olanzapine initiation. Clinical measures to document symptom improvement were done at medication initiation and 6 months later.

Results

  • 85% reduction in inpatient utilization occurred after medication was initiated.

  • 80% reduction in acute ER utilization

  • 23% increase in outpatient services correlating with greater patient stabilization

  • Overall mean costs savings of $296 per pt/month. (n=56)

  • Significant  improvement in symptoms of schizophrenia


Service Utilization Changes

top


Intent to Treat: Cost Changes

top


Mean Cost Changes Over 2 Years

top